Mar 14 2024
GoodRx Interim CEO Extends Commitment to Company
Company Announces Board Resignations SANTA MONICA, Calif. --(BUSINESS WIRE)--Mar. 14, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S. , today announced Interim CEO Scott Wagner has extended his commitment to the Company.
PDF Version
Feb 29 2024
GoodRx Reports Fourth Quarter and Full Year 2023 Results
SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 29, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S. , has released its financial results for the fourth quarter and full year 2023, which are consistent with its
PDF Version
Feb 20 2024
GoodRx to Participate in Upcoming Investor Conferences
SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 20, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S. , today announced that executives from the Company will participate in a fireside chat at each of the following
PDF Version
Jan 22 2024
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 22, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien
PDF Version